Carlyle Group agreed to invest 1.78 billion yuan ($260 million) to buy a minority stake in Shenzhen Salubris Pharmaceutical Co., bringing its announced investment in health-care companies in Asia this year to almost $1 billion. The U.S. fund will acquire a 5% stake in...
European healthcare investment firm ArchiMed SAS has agreed to acquire a majority state in medical device testing company Namsa, the two businesses said. ArchiMed prevailed in a sales process for the business, also known as North American Science Associates, over...
Brazilian private equity firm Patria Investimentos has raised a 10 billion-real ($2 billion) fund to invest in infrastructure in Brazil and elsewhere in Latin America, it said on Monday, adding that logistics, energy and telecoms would be key targets. The...
Chinese data centre owner ChinData Group is preparing to file confidentially for a U.S. IPO to raise up to $400 million as it becomes the latest mainland firm to seek a New York listing, two sources with direct knowledge of the matter said. The Bain Capital backed...
Thoma Bravo, a private equity firm focused on technology and software, later this fall aims to wrap up fundraising for three funds, which could potentially haul in a total of more than $21bn, according to people familiar with the matter. The funds would rank as one of... 